Le Directeur général de l’OMS, le Dr Tedros Adhanom Ghebreyesus, a estimé que la recrudescence de variole simienne (mpox) en République démocratique du Congo (RDC) et dans un nombre croissant de pays d’Afrique constituait une urgence de santé publique de portée internationale (USPPI) au t...itre du Règlement sanitaire international (2005) (RSI).
more
Une flambée de maladie connue sous le nom de « variole du singe » sévit actuellement dans de nombreux pays où il n’y a généralement pas de cas. Cette situation peut être préoccupante, notamment pour les personnes dont les proches ou la communauté sont touchés. Certains cas ont été obs...ervés dans des centres de santé sexuelle parmi les homosexuels, les bisexuels et les autres hommes qui ont des rapports sexuels avec des hommes.
more
L’orthopoxvirus simien ou virus de la variole du singe (MPXV), est un virus à ADN double brin qui appartient au genre Orthopoxvirus de la famille
des Poxviridés. Les poxvirus causent des maladies chez l’espèce humaine et beaucoup d’autres animaux ; l’infection se manifeste généralement... par la formation de lésions, de nodules cutanés ou d’une éruption cutanée disséminée. Les autres espèces d’orthopoxvirus (OPXV) pathogènes pour l’être humain comprennent le virus de la variole bovine et le virus variolique (responsable de la variole, qui a été éradiquée). Le virus de la vaccine est également un OPXV qui a été utilisé pour la vaccination humaine, et a été un outil essentiel pour l’éradication de la variole, obtenue en 1980. Le MPXV doit son nom au fait qu’il a été identifié pour la première fois chez le singe. Le MPXV se retrouve principalement chez les rongeurs, mais son réservoir reste indéterminé. Il existe deux clades connus du MPXV, l’un endémique en Afrique de l’Ouest, et l’autre dans la région du bassin du Congo.
more
The tab is the result of a preliminary landscape of therapeutics licensed or under development for Mpox
The tab is the result of a preliminary landscape of vaccines licensed or under development for Mpox
This is the 35th situation report for the multi-country outbreak of mpox, which provides details on the latest epidemiological trends, including an update on the geographic expansion of mpox in the WHO African Region from July – August 2024.
This document is the ninth in a series of Tobacco Knowledge Summaries and is prepared with the objective to summarize the current evidence on the association between tobacco use and asthma. This is also intended as an advocacy tool to widely include health care professionals, in particular pulmonolo...gists and respirologists, in the fight for tobacco control and prevention of tobacco related adverse health effects. This knowledge summary was prepared by World Health Organization in collaboration with the Forum of International Respiratory Societies, the Global Initiative for Asthma and The University of Tasmania.
more
The Country Cooperation Strategy (CCS) is a medium-term strategic framework for cooperation between WHO and countries and outlines a shared agenda with priority areas of work for five years. The aim of this CSS is to define medium term vision for
WHO technical cooperation with the State of Eritrea ...for a 5-year period, 2023-2027, in support of the country’s Health Sector Strategic and Development Plan III (HSSDPIII) 2022-2026 aimed at improving the health status of its people
more
Preparedness and Resilience for Emerging Threats in English, Spanish and French
These guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates to WHO guidelines on HTS, with a focus on new evidence, new recommendations, good practices and operational considerations that respond to the changing ne...eds of national programmes.
more
The Mekong Malaria Elimination (MME) programme is an initiative aimed at supporting Greater Mekong Subregion (GMS) countries – Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, and Yunnan (China) – in achieving the goal of malaria elimination by 2030. Data for this epidemi...ological summary were compiled from country reports. Between January and March 2024, 22 632 malaria cases were reported. During that period, GMS countries recorded 28% fewer cases, with P. falciparum + mixed and P. vivax cases declining by 50% and 23%, respectively. Meanwhile, testing declined by 21% when compared to the same period in 2023.
more
Como disciplina, la salud pública comenzó en las ciudades. Sin embargo, debido al rápido aumento
de las tasas de urbanización en todo el mundo, muchas ciudades también están exponiendo
involuntariamente a sus ciudadanos a factores de riesgo de dos amenazas para la salud que se
cobran millon...es de vidas cada año: las enfermedades no transmisibles (ENT) y los traumatismos
more
En mai 2023, la COVID-19 n’est peut-être plus classifiée en tant qu’urgence de santé publique d’envergure internationale mais nous ne devons pas ignorer les profonds problèmes structurels qu’elle a révélé dans notre économie. La santé est
un droit humain fondamental et le temps est... venu de réorienter et de réorganiser l’économie pour atteindre l’objectif de la Santé pour tous.
more
This resource presents a comprehensive framework designed to enhance and streamline telemedicine services within health-care systems. It addresses the critical need for accessible and effective telemedicine solutions, especially in the face of global health challenges and the evolving demands on hea...lth-care infrastructures. It outlines a multidimensional strategy that includes an assessment of the current health-care ecosystem, strategic visioning for telemedicine integration, organizational change management, development of telemedicine services, and continuous monitoring, evaluation, and optimization. It emphasizes the importance of considering the unique needs of diverse populations and ensuring equitable access to telemedicine technologies. By leveraging global best practices and empirical evidence, the document aims to guide stakeholders through the lifecycle of telemedicine service implementation—from conceptualization to maturity. Intended for health-care decision-makers, policy-makers, and telemedicine practitioners, the framework supports the development of high-quality telemedicine services at various levels of the health system. It facilitates a collaborative approach, encouraging alignment and coordination among different stakeholders to achieve a common goal: building a resilient, patient-centred, and technologically advanced health-care system.
more
Identifying and addressing immunization inequities is core to the success of immunization programmes and will require a collective effort from all parts of the immunization programme, working in partnership with governments and other areas of health. This document provides practical guidance for tho...se working in immunization programmes to help advocate for immunization equity, embed equity as am aim in delivery of immunization programmes, and understand existing inequities by considering: who is left behind; why they were left behind; how we can intervene to resolve and avoid this; and whether our intervention has made a difference.
more
In 2015, Member States and the global health community committed to reduce premature mortality from
noncommunicable diseases (NCDs) by one third by 2030 (SDG target 3.4). Despite growing efforts, the pace of change in
most countries, and the policies and regulations required to achieve this goal, ...are too slow, inadequate or insufficient.
Recognizing that public sector efforts alone are insufficient to address the prevention and control of NCDs, the Global
NCD Action Plan emphasizes the need for coordinated multisectoral and multistakeholder engagement, acknowledging
the role of nongovernmental organizations – including civil society groups, individuals with lived experience, academic
institutions and private sector entities. However, WHO notes that some Member States still have limited or no capacity
to establish or manage the implementation of engagement with private sector entities for the prevention and control of
noncommunicable diseases
more